Adjuvant Holdings Co (TSE:4929) Marketable Securities: 円0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4929 Adjuvant Holdings Co Ltd TSE:4929
59 GF Score
Price 円737.00
GF Value 円732.98
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Adjuvant Holdings Co Marketable Securities?

Adjuvant Holdings Co TSE:4929 -0.14% 59 Marketable Securities is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:4929 with a GF Score™ of 59/100 and a GF Value™ of 円732.98 (Fairly Valued). The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Adjuvant Holdings Co's Marketable Securities for the quarter that ended in Mar. 2026 was 円0 Mil.

Adjuvant Holdings Co  (TSE:4929) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Adjuvant Holdings Co Marketable Securities Related Terms

Adjuvant Holdings Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Adjuvant Holdings Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adjuvant Holdings Co Marketable Securities Chart

Adjuvant Holdings Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Adjuvant Holdings Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4929
59GF Score
Adjuvant Holdings Co Ltd TSE:4929
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adjuvant Holdings Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of 円0 Mil mean?
Adjuvant Holdings Co (TSE:4929) has a Marketable Securities of 円0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Adjuvant Holdings Co and its competitors.
Is Adjuvant Holdings Co's Marketable Securities too high?
Adjuvant Holdings Co's current Marketable Securities is 円0 Mil. Overall, Adjuvant Holdings Co has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adjuvant Holdings Co's Marketable Securities compare to PG and CL?
Adjuvant Holdings Co's Marketable Securities of 円0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Consumer Packaged Goods company?
A good Marketable Securities depends on the Consumer Packaged Goods industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Adjuvant Holdings Co and its competitors. Adjuvant Holdings Co's current Marketable Securities is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adjuvant Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Adjuvant Holdings Co (TSE:4929) is currently considered Fairly Valued. The stock's GF Value™ is 円732.98, compared to a current price of 円737.00 — trading 0.5% above its estimated fair value. The current Marketable Securities is 円0 Mil. Adjuvant Holdings Co's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Adjuvant Holdings Co (TSE:4929), the current Marketable Securities is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adjuvant Holdings Co (TSE:4929) Overvalued in 2026?

Based on GuruFocus' analysis, Adjuvant Holdings Co stock appears to be overvalued. The current stock price of 円737.00 is trading 0.5% above its estimated GF Value™ of 円732.98. GuruFocus considers Adjuvant Holdings Co to be Fairly Valued.

Key valuation signals for TSE:4929:

  • Marketable Securities: 円0 Mil
  • GF Value™: 円732.98 vs. price of 円737.00 (0.5% above fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the TSE:4929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adjuvant Holdings Co Business Description

Address 5-5-5 Shimoyamatedori, Chuo-ku, Hyogo Prefecture, Kobe City, JPN, 650-0011
Adjuvant Holdings Co Ltd, formerly Adjuvant Cosme Japan Co Ltd is engaged in the research, development, production, and sale of cosmetics in Japan. It offers skin care products, including cleansing products, facial cleansers, lotions, beauty essences, masks, moisturizing creams, makeup bases, makeup, and body care products among other products.
59GF Score

Get the complete analysis for TSE:4929

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円737.00
Price
円732.98
GF Value